{{Rsnum
|rsid=10788160
|Chromosome=10
|position=123033549
|Orientation=plus
|GMAF=0.174
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.1 | 32.3 | 64.6
| HCB | 0.0 | 37.8 | 62.2
| JPT | 2.3 | 20.5 | 77.3
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 3.7 | 96.3
| CHB | 0.0 | 37.8 | 62.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 3.7 | 96.3
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21160077
|Trait=None
|Title=Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels
|RiskAllele=A
|Pval=5E-15
|OR=10.2000
|ORtxt=[NR] % increase
|OA=1
}}

{{PMID Auto
|PMID=23937305
|Title=Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer
}}

{{PMID Auto
|PMID=24345439
|Title=Prostate cancer risk alleles are associated with prostate cancer tumor volume and prostate size
}}

{{PMID Auto
|PMID=23246478
|Title=Personalized prostate specific antigen testing using genetic variants may reduce unnecessary prostate biopsies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}